Added to YB: 2017-09-06
Pitch date: 2017-09-06
SNDX:US [bullish]
Syndax Pharmaceuticals, Inc.
+126.2%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
Market Cap
$1.9B
Pitch Price
$8.74
Price Target
N/A
Dividend
N/A
EV/EBITDA
-8.22
P/E
-7.48
EV/Sales
8.45
Sector
Biotechnology
Category
N/A
Show full summary:
Syndax Pharmaceuticals Inc SNDX:US
A summary for this pitch has not been created yet.
Read full article (0 min)